203 related articles for article (PubMed ID: 28569052)
1. Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis.
Bonella F; Long X; He X; Ohshimo S; Griese M; Guzman J; Costabel U
Respirology; 2017 Oct; 22(7):1371-1378. PubMed ID: 28569052
[TBL] [Abstract][Full Text] [Related]
2. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis.
Long X; He X; Ohshimo S; Griese M; Sarria R; Guzman J; Costabel U; Bonella F
Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 27836954
[TBL] [Abstract][Full Text] [Related]
3. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
Korthagen NM; van Moorsel CH; Barlo NP; Ruven HJ; Kruit A; Heron M; van den Bosch JM; Grutters JC
Respir Med; 2011 Jan; 105(1):106-13. PubMed ID: 20888745
[TBL] [Abstract][Full Text] [Related]
4. Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis.
Bonella F; Ohshimo S; Miaotian C; Griese M; Guzman J; Costabel U
Orphanet J Rare Dis; 2013 Apr; 8():53. PubMed ID: 23557396
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis.
Furuhashi K; Suda T; Nakamura Y; Inui N; Hashimoto D; Miwa S; Hayakawa H; Kusagaya H; Nakano Y; Nakamura H; Chida K
Respir Med; 2010 Aug; 104(8):1204-10. PubMed ID: 20347285
[TBL] [Abstract][Full Text] [Related]
6. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
Hozumi H; Fujisawa T; Enomoto N; Nakashima R; Enomoto Y; Suzuki Y; Kono M; Karayama M; Furuhashi K; Murakami A; Inui N; Nakamura Y; Mimori T; Suda T
J Rheumatol; 2017 Sep; 44(9):1394-1401. PubMed ID: 28711881
[TBL] [Abstract][Full Text] [Related]
7. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis.
Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S
Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097
[TBL] [Abstract][Full Text] [Related]
8. [Serum markers in patients with idiopathic pulmonary alveolar proteinosis].
Li Y; Tian X; Gui Y; Ma A; Li X; Zeng N; Zhang P; Li G; Xu K
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):497-501. PubMed ID: 25262689
[TBL] [Abstract][Full Text] [Related]
9. Elevation of tumour markers in serum and bronchoalveolar lavage fluid in pulmonary alveolar proteinosis.
Hirakata Y; Kobayashi J; Sugama Y; Kitamura S
Eur Respir J; 1995 May; 8(5):689-96. PubMed ID: 7656937
[TBL] [Abstract][Full Text] [Related]
10. MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis.
Bonella F; Long X; Ohshimo S; Horimasu Y; Griese M; Guzman J; Kohno N; Costabel U
Orphanet J Rare Dis; 2016 Apr; 11():48. PubMed ID: 27108412
[TBL] [Abstract][Full Text] [Related]
11. Can YKL-40 be used as a biomarker for interstitial lung disease?: A systematic review and meta-analysis.
Tong X; Ma Y; Liu T; Li Z; Liu S; Wu G; Fan H
Medicine (Baltimore); 2021 Apr; 100(17):e25631. PubMed ID: 33907118
[TBL] [Abstract][Full Text] [Related]
12. Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis.
Iyonaga K; Suga M; Yamamoto T; Ichiyasu H; Miyakawa H; Ando M
Eur Respir J; 1999 Aug; 14(2):383-9. PubMed ID: 10515418
[TBL] [Abstract][Full Text] [Related]
13. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis.
Takahashi T; Munakata M; Suzuki I; Kawakami Y
Am J Respir Crit Care Med; 1998 Oct; 158(4):1294-8. PubMed ID: 9769294
[TBL] [Abstract][Full Text] [Related]
14. Extracellular 20S proteasome in BAL and serum of patients with alveolar proteinosis.
Bonella F; Sixt SU; Thomassen J; Schmidt M; Cai M; Mori T; Guzman J; Costabel U
Immunobiology; 2015 Mar; 220(3):382-8. PubMed ID: 25534398
[TBL] [Abstract][Full Text] [Related]
15. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
Jaksch P; Taghavi S; Klepetko W; Salama M
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
[TBL] [Abstract][Full Text] [Related]
16. YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children.
Yang X; Sheng G
BMC Pediatr; 2018 Dec; 18(1):381. PubMed ID: 30514252
[TBL] [Abstract][Full Text] [Related]
17. Whole Lung Lavage Treatment of Chinese Patients with Autoimmune Pulmonary Alveolar Proteinosis: A Retrospective Long-term Follow-up Study.
Zhao YY; Huang H; Liu YZ; Song XY; Li S; Xu ZJ
Chin Med J (Engl); 2015 Oct; 128(20):2714-9. PubMed ID: 26481735
[TBL] [Abstract][Full Text] [Related]
18. B cell-activating factors in autoimmune pulmonary alveolar proteinosis.
Hirose M; Arai T; Sugimoto C; Takimoto T; Sugawara R; Minomo S; Shintani S; Takeuchi N; Katayama K; Inoue Y; Kagawa T; Kasai T; Akira M; Inoue Y
Orphanet J Rare Dis; 2021 Mar; 16(1):115. PubMed ID: 33653382
[TBL] [Abstract][Full Text] [Related]
19. Elevated tumor markers in patients with pulmonary alveolar proteinosis.
Fang SC; Lu KH; Wang CY; Zhang HT; Zhang YM
Clin Chem Lab Med; 2013 Jul; 51(7):1493-8. PubMed ID: 23314555
[TBL] [Abstract][Full Text] [Related]
20. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
